Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors

dc.contributor.author	Geisler, Tobias
dc.date.accessioned	2019-04-23T12:22:36Z
dc.date.available	2019-04-23T12:22:36Z
dc.date.issued	2017
dc.identifier.issn	2055-6845
dc.identifier.uri	http://hdl.handle.net/10900/87992
dc.language.iso	en	de_DE
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/ehjcvp/pvw044	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_00918
utue.publikation.seiten	221-234	de_DE
utue.personen.roh	Winter, Max-Paul
utue.personen.roh	Grove, Erik L.
utue.personen.roh	De Caterina, Raffaele
utue.personen.roh	Gorog, Diana A.
utue.personen.roh	Ahrens, Ingo
utue.personen.roh	Geisler, Tobias
utue.personen.roh	Gurbel, Paul A.
utue.personen.roh	Tantry, Udaya
utue.personen.roh	Navarese, Eliano P.
utue.personen.roh	Siller-Matula, Jolanta M.
dcterms.isPartOf.ZSTitelID	European Heart Journal - Cardiovascular Pharmacotherapy	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	3	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE

Files in this item

Files	Size	Format	View
There are no files associated with this item.